Scientists Designed a Drug for Just One Patient. Her Name Is Mila.

An achievement in ultra-personalized medicine also raises questions about fairness and regulation. BY GINA KOLATA https://ift.tt/2M3uikJ https://ift.tt/2IDu8yh New York Times Health Drugs (Pharmaceuticals), Genetics and Heredity, Disabilities, Ataxia-Telangiectasia (Genetic Disease), Medicine and Health, Children and Childhood October 9, 2019 at 11:57PM